Friday October 4 2019 - Speakers and Titles are Subject to Change
Registration   7:00-8:00
Conference Opening    8:00-8:10

Session I: The Current Landscape - Updates

Chair:  TBA

Talk Title Speaker Company Time
Session Introduction     8:10-8:15
Current Landscape for the Treatment of Patients with Acute Myeloid Leukemia Daniel DeAngelo Dana Farber Cancer Institute 8:15-8:40
Q&A     8:40-8:50
Application of Clinical and Functional Genomics to Pediatric AML Kimberly Stegmaier Harvard Medical School/DFCI 8:50-9:15
Q&A     9:15-9:25
AM Break     9:25-9:45

Session II: State of the Art Research and Treatment Updates

Chair: TBA

Talk Title Speaker Company Time
 Session Introduction     9:45-9:50
Optimizing CAR T Cell for AML: What can we learn from experience in ALL  Terry Fry  Children's Hospital Colorado 9:50-10:15
Q&A     10:15-10:25
Defining a Role for BH3 Mimetics in High Risk Myeloid Malignancies  Jacqueline Garcia  Dana Farber Cancer Center 10:25-10:50
Q&A     10:50-11:00
Epigenetic targets of R-2-hydroxyglutarate in IDH mutant tumors: Beyond TET2  Julie-Aurore Losman Dana Farber Cancer Center 11:00-11:25
Q&A     11:25-11:35
Lunch and Networking Hour     11:35-1:05
State of the Art Research and Treatment Updates: Advances in the Management of TP53 mutant Acute Myeloid Leukemia  David Sallman Moffitt Cancer Center 1:05-1:30
Q&A     1:30-1:40
Emerging Immune-based Therapies in AML  Mikael Rinne Novartis Institutes for Biomedical Research 1:40-2:05
Q&A   2:05-2:15

Session III: On the Horizon

Chair: TBA

Talk Title Speaker Company Time
 Session Introduction     2:15-2:20
Recent Drug Approvals in Acute Myeloid Leukemia Kelly Norsworthy FDA 2:20-2:45
Q&A     2:45-2:55
PM Break     2:55-3:15
LLS Children's Initiative Gwen Nichols The Leukemia and Lymphoma Society 3:15-3:40
Q&A     3:40-3:50
Enabling Genomic Actionability in the Clinic  Jeffrey Venstrom Foundation Medicine 3:50-4:20
Q&A     4:20-4:30
Closing Remarks   4:30-4:35
Evening Reception hosted by The Boston Society       4:35-6:05

Sessions

Session I:  The Current Landscape - Updates

Session II:  Session II - State of the Art Research and Treatment Updates

Session III:  On the Horizon

Registration

Click here to register for the AML 2021 conference online.

AML 2021 will be fully virtual

October 22, 2021

 

 

The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3

Updates

Sign Up Today!

Privacy Policy